Loading...
Long-term real-world experience with ipilimumab and non-ipilimumab therapies in advanced melanoma: the IMAGE study
BACKGROUND: Ipilimumab has shown long-term overall survival (OS) in patients with advanced melanoma in clinical trials, but robust real-world evidence is lacking. We present long-term outcomes from the IMAGE study (NCT01511913) in patients receiving ipilimumab and/or non-ipilimumab (any approved tre...
Saved in:
| Published in: | BMC Cancer |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
BioMed Central
2021
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8164785/ https://ncbi.nlm.nih.gov/pubmed/34051732 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-021-08032-y |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|